I read with great interest the report by Kouskoff et al . ([1][1]), in which the authors used an immunoglobulin M (IgM) nonswitchable B cell transgenic (Tg) mouse to show that the B cells could be made to react against a phage exhibiting a cross-reactive antigenic determinant of 20 amino acids in a
No takes yet. Share an insight, caveat, or question.
Rolf M. Zinkernagel (2000) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: